-
Scotland seeks answers on Brexit costs to NHS
pharmaceutical-technology
November 07, 2018
Scotland First Minister Nicola Sturgeon has urged the UK government to provide answers on how much Brexit will cost the country’s National Health Service (NHS).
-
Industry leaders warn public may have to stockpile medicines in case of no-deal Brexit
pharmafile
October 25, 2018
Martin Sawer, the executive director of the Healthcare Distribution Association (HDA) – formerly the British Association of Pharmaceutical Wholesalers (BAPW) – has told MPs that a no-deal Brexit...
-
Researchers warn of impact of no-deal Brexit on UK science
pharmaceutical-technology
October 24, 2018
UK biomedical research lab Francis Crick Institute has warned that a hard or ‘no-deal’ Brexit could negatively impact the science and research across the country.
-
ABPI tells MPs Brexit deal on medicines regulation ‘urgently needed’
pharmatimes
October 12, 2018
Pharmaceutical companies “are doing everything in their power” to minimise disruption to the supply of medicines should the UK leave the EU under a ‘no-deal’ scenario...
-
EMA Brexit preparedness business continuity plan enters third phase
expressbpd
October 11, 2018
The European Medicines Agency’s (EMA) Brexit preparedness BCP entered into its third phase recently as announced at the beginning of August 2018.
-
MHRA consults on new regulatory framework for ‘no-deal’ scenario
pharmatimes
October 11, 2018
The Medicines and Healthcare products Regulatory Agency has launched a consultation seeking views on how its legislation and regulatory processes would have to be modified...
-
EMA feeling better about drug supply interruptions from Brexit
fiercepharma
September 27, 2018
The European Medicines Agency says concerns over drug supply shortages stemming from Brexit have eased, but not all drugmakers feel the same.
-
Leaked letter warns of NHS disruption after Brexit
pharmafile
August 22, 2018
NHS Providers, the membership organisation and trade association for professionals working in the NHS, has warned that the NHS is unprepared for Brexit in a letter leaked to The Times newspaper.
-
MHRA sets out Brexit implementation period plan
pharmafile
August 08, 2018
The UK Medicines and Healthcare products Regulatory Agency (MHRA) have released an update which sets out what pharmaceutical and healthcare companies should expect from the Brexit implementation period that will run from March 2019 to December 2020.
-
U.K. commits to adopt EU trial regulation, minimize divergence after Brexit
fiercebiotech
August 08, 2018
The U.K. regulatory agency has detailed how it expects Brexit to affect its clinical trial regulations. Officials reiterated their intent for the U.K. to implement the incoming European Union Clinical Trials Regulation (CTR) and expanded on the long-term